Stock Rich List
#4707 on the rich list of 14,644 insiders

Matthew B. Klein

CHIEF EXECUTIVE OFFICER at PTC Therapeutics; Director at ClearPoint Neuro. Based in Warren, New Jersey.

$22.7M
in disclosed stock, −$750K (−3.19%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
4707th of 14,644
Companies held
2
Largest holding
PTCT, 98.5% of total
Latest SEC filing
Aug 4, 2026

What the $22.7M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
PTC Therapeutics PTCT
Common Stock
Directly383,868$58.33$22.4M98.5%Form 4, Aug 4, 2026
ClearPoint Neuro CLPT
Common Stock
Directly46,935$7.31$343K1.5%Form 4, May 21, 2026

Share counts are the amounts Matthew B. Klein reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Aug 4, 2026SoldPTCT10,292$68.57$706KView
May 21, 2026SoldCLPT16,000$11.59$185KView
May 14, 2026SoldPTCT7,221$73.08$528KView
May 14, 2026SoldPTCT679$73.06$50KView
May 14, 2026SoldPTCT2,100$73.08$153KView
May 14, 2026SoldPTCT2,572$72.46$186KView
Apr 21, 2026SoldPTCT2,850$70.91$202KView
Mar 12, 2026SoldPTCT2,662$64.08$171KView
Feb 18, 2026SoldPTCT7,371$69.36$511KView
Jan 8, 2026SoldPTCT2,514$76.45$192KView
Jan 7, 2026SoldPTCT3,016$77.48$234KView
Jan 6, 2026SoldPTCT5,149$76.95$396KView
Dec 30, 2025SoldPTCT8,089$76.64$620KView
Dec 2, 2025SoldPTCT3,428$79.07$271KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
4704Ken S. Ansin
Director, Independent Bank. Rockland, MA
$22.7M−$589K (−2.52%)
4705Robert H. Herz
Director, Morgan Stanley. Ames, IA
$22.7M−$774K (−3.29%)
4706Mark Garrett
Director, Snowflake. Menlo Park, CA
$22.7M−$742K (−3.16%)
4707Matthew B. Klein
CHIEF EXECUTIVE OFFICER, PTC Therapeutics. Warren, NJ
$22.7M−$750K (−3.19%)
4708Matthew V. Hairford
President, Matador Resources. Dallas, TX
$22.7M$0 (0.00%)
4709William K. Hood
Director, First Guaranty Bancshares. Hammond, LA
$22.7M−$139K (−0.61%)
4710Thomas Nichols Thompson
Director, Truist Financial. Charlotte, NC
$22.7M−$515K (−2.22%)

Other PTC Therapeutics insiders

All PTCT insiders

Questions

How much stock does Matthew B. Klein own?

Matthew B. Klein holds $22,732,196 in listed stock based on SEC filings and current prices, mostly PTC Therapeutics (PTCT). That ranks 4707th on the Stock Rich List.

Is this Matthew B. Klein's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Matthew B. Klein last buy or sell stock?

The most recent open-market trade on file is a sale of 10,292 PTCT shares on Aug 4, 2026 at $68.57.